Dhanvantari Nano Ayushadi

Dhanvantari Nano Ayushadi (DNA), operating under the brand name NanOlife, is an Indian biotechnology company that develops next-generation Ayurvedic and nanomedicine products. The company utilizes a patented green nanotechnology platform licensed from the University of Missouri, developed by Dr. Kattesh V. Katti, to produce non-toxic, clinically effective phytonanomedicines. Its lead program, DNANOSTANNA (Nano Swarna Bhasma), is a gold nanoparticle-based formulation encapsulated with plant-derived phytochemicals that has completed pilot clinical trials for the treatment of metastatic breast cancer. Additionally, the company develops silver-based antimicrobial and anti-infective products for healthcare and household decontamination.